WASHINGTON--(BUSINESS WIRE)--SteadyMed Ltd., an Israeli company based in Tel Aviv (“SteadyMed” or the “Company”), closed a $2 million round of funding from US investors. The round was led by Samson Venture Partners, LLC (“Samson Venture Partners”), the investment management arm of Becker & Associates Consulting, Inc., an FDA consulting firm in Washington, DC specializing in innovative medical devices and drugs.
